Board Meeting21 Jul 2026, 04:40 pm
Anthem Biosciences Board Approves Unaudited Financial Results for Q1 FY27
AI Summary
Anthem Biosciences Limited announced that its Board of Directors, in a meeting held on July 21, 2026, approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The results were reviewed and recommended by the Audit Committee. The company will publish an extract of these results in newspapers as required by SEBI LODR regulations and has also made them available on its website.
Key Highlights
- Board meeting held on July 21, 2026.
- Approved Unaudited Standalone Financial Results for Q1 FY27.
- Approved Unaudited Consolidated Financial Results for Q1 FY27.
- Results recommended by the Audit Committee.
- Financial results to be published in newspapers.
Price Impact
More from ANTHEM